Jennison Associates’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$111M Buy
4,508,395
+1,387,730
+44% +$32.1M 0.07% 149
2026
Q1
$74.7M Buy
3,120,665
+494,216
+19% +$12.1M 0.05% 168
2025
Q4
$59.4M Sell
2,626,449
-1,347,898
-34% -$29.3M 0.04% 184
2025
Q3
$80M Buy
3,974,347
+739,630
+23% +$12.4M 0.05% 157
2025
Q2
$46.2M Buy
3,234,717
+2,468,122
+322% +$28.8M 0.03% 229
2025
Q1
$8.05M Sell
766,595
-329,115
-30% -$3.72M 0.01% 392
2024
Q4
$13.3M Buy
1,095,710
+15,246
+1% +$199K 0.01% 379
2024
Q3
$15.9M Buy
1,080,464
+448,368
+71% +$6.25M 0.01% 363
2024
Q2
$9.12M Buy
+632,096
New +$10.1M 0.01% 389
2020
Q1
Sell
-448,970
Closed -$13.2M 646
2019
Q4
$13.2M Sell
448,970
-467,443
-51% -$12.7M 0.01% 356
2019
Q3
$24.4M Sell
916,413
-11,927
-1% -$358K 0.03% 288
2019
Q2
$31.4M Buy
928,340
+127,111
+16% +$4.13M 0.03% 277
2019
Q1
$25.7M Buy
801,229
+119,777
+18% +$3.69M 0.03% 320
2018
Q4
$21.5M Buy
681,452
+281,452
+70% +$9.21M 0.02% 343
2018
Q3
$14M Buy
+400,000
New +$14.1M 0.01% 440

Other funds holding ELAN

Jennison Associates's ELAN Position: Q2 2026 in Review

Jennison Associates increased its Elanco Animal Health (ELAN) stake by 44% in Q2 2026, buying an estimated $32.1M and bringing the position to 4,508,395 shares worth $111M. The position accounts for 0.07% of the portfolio, ranked #149.

Jennison Associates first reported a position in ELAN in Q3 2018 and has held it in 15 quarters since. 520 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Jennison Associates held 4,508,395 shares of Elanco Animal Health worth $111M as of Q2 2026.
  • Jennison Associates bought 1,387,730 Elanco Animal Health shares in Q2 2026, an estimated $32.1M.
  • Elanco Animal Health made up 0.07% of Jennison Associates's portfolio in Q2 2026, its #149 holding.
  • Jennison Associates first reported a position in Elanco Animal Health in Q3 2018 and has held it in 15 quarters since.
  • 520 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Jennison Associates's 13F filing for Q2 2026, filed 3 Aug 2026.